In a previous study from our group, S100B release was strongly increased in chronic gut inflammation, and this might, in turn, offer mechanistic insights into the transition from chronic inflammatory conditions, such as ulcerative colitis (UC) to colorectal cancer [38]. Here, S100B is linked to inflammation.